Search

Search Constraints

You searched for: Author/Creator Knopman, David S.

Search Results

481. Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. (7th July 2020)

482. Utility of ioflupane‐SPECT with multimodal imaging in dementia with Lewy bodies: Neuroimaging / multi‐modal comparisons. (7th December 2020)

483. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. (13th January 2015)

484. Vascular Imaging Abnormalities and Cognition. Issue 2 (February 2015)

485. Vascular Imaging Abnormalities and Cognition: Mediation by Cortical Volume in Nondemented Individuals. Issue 2 (February 2015)

486. Version 3 of the National Alzheimer's Coordinating Center's Uniform Data Set. (October 2018)

487. Weighting and standardization of frequencies to determine prevalence of AD imaging biomarkers. (14th November 2017)

488. White matter changes in empirically derived incident MCI subtypes in the Mayo Clinic Study of Aging. Issue 1 (31st December 2021)

489. White Matter Degeneration Pathways Associated with Tau Deposition in Alzheimer's Disease. (20th December 2022)

490. White matter health in the context of Alzheimer's disease pathophysiology. (20th December 2022)